kezar life sciences news
5 hours agoInvestors are always looking for stocks that are poised to beat at earnings season and Kezar Life Sciences Inc. Some of the losses seen.
Kezar Life Sciences Kzr Stock Why The Price Surged Today
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635c4 Apr 15 2022 405pm EDT.
. South san francisco calif-- business wire-- kezar life sciences inc. Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635c4 SOUTH SAN FRANCISCO Calif April 15 2022-. Possible turnaround for Kezar Life Sciences Inc.
The company reported 025 EPS for the quarter topping the consensus estimate of. 468209 shares have. Kezar Life Sciences climbs after over 1 million insider purchase Benzinga 43d Heres Why Kezar Life Sciences Shares Are Moving Seeking Alpha 43d.
May 10 2022 838AM EDT. Kezar Life Sciences Inc. Uniquely Powerful Approaches to Tackling the Toughest Diseases Our Story Latest News April 15 2022 Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635 c 4 April 15 2022 Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635 c 4 March 17 2022.
KZR may be one such company. Kezar Life Sciences Announces Interim Results from the MISSION Phase 2 Trial in Patients with Lupus Nephritis. Is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco.
Kezar Life Sciences is a clinical-stage biotechnology company. Kezar Life Sciences has a 52 week low of 461 and a 52 week high of 1855. Kezar Life Sciences Inc.
Recent News View All News. Kezar Life Sciences KZR-616 an Orphan Drug in US. May 10 2022 Finance The trading price of Kezar Life Sciences Inc.
Nov 15 2021 405pm EST. Kezar Life Sciences Inc. Today Kezar Life Sciences Inc NASDAQ.
On average they expect Kezar Life Sciences stock price to reach 1667 in the next year. Kezar Life Sciences stock opened at 1833 on Wednesday. This week the Dow Jones Industrial Average rose 39 and the SP 500 rose 49.
The business has a 50-day simple moving average of 1408 and. Kezar Life Sciences Inc KZR shares closed today at 07 below its 52 week high of 1634 giving the company a market cap of 775M. 23 2020 Encouraging lupus data lifts Kezar Life Sciences up 9 after hours.
NASDAQKZR insiders still down US17k after a US13m shopping spree. For autoimmune inflammatory disorders SA News Fri Oct. 5 Best Growth Stocks for 2022.
Investors are always looking for stocks that are poised to beat at earnings season and Kezar Life Sciences Inc. Kzr a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders today reported interim results from the phase 2 portion of its mission clinical trial evaluating kzr-616 a first-in-class. Kezar Life dropped 0255 in trading today.
4000 Shoreline Court Suite 300 South San Francisco CA 94080 T. According to data from Benzinga. Kezar Life Sciences Inc.
Kezar Life Sciences NASDAQKZR Get Rating last issued its quarterly earnings data on Thursday March 17th. Their forecasts range from 1400 to 2200. The firm has earnings.
Kezar Life Sciences is a clinical-stage biopharmaceutical company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders. South san francisco calif april 15 2022--kezar life sciences inc nasdaq. The stock is currently up 2023 year-to-date up 1833 over the past 12 months and down 111 over the past five years.
NASDAQKZR closed lower on Monday May 09 closing at 571 -951 lower than its previous close. View analysts price targets for Kezar Life Sciences or view top-rated stocks among Wall Street analysts. The firm has earnings coming.
KZR Quick Quote KZR - Free Report may be one such company. Kzr a clinical-stage biotechnology company discovering and developing breakthrough treatments for. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
This suggests a possible upside of 1641 from the stocks current price. KZR is trading 404 lower. The latest price as of 120431 est was 601.
Kezar Life Sciences News Headlines 1481 025 172 As of 04192022 1210 PM ET Todays Range 1436 1500 50-Day Range 1304 1833 52-Week Range 461 1855 Volume 6231 shs Average Volume 624702 shs Market Capitalization 83992 million PE Ratio NA Dividend Yield NA Beta 027 Profile Analyst Ratings Chart Competitors. Shares of clinical-stage drug developer Kezar Life Sciences plunged more than 24 to 935 in after-hours trading on Tuesday as the company announced mixed top-line results from the PRESIDIO Phase II clinical trial of zetomipzomib formerly KZR-616 in patients with dermatomyositis DM and polymyositis PM.
Kezar Life Sciences Inc Kzr Stock Price News Info The Motley Fool
Kezar Life Sciences Crashes After Setback To Lead Asset In Mid Stage Trial Nasdaq Kzr Seeking Alpha
Kezar Life Sciences Raises 75 Million In Slightly Upsized Ipo Silicon Valley Business Journal
Kezar Life Sciences Announces Pricing Of Initial Public Offering
Could The Kezar Life Sciences Inc Nasdaq Kzr Ownership Structure Tell Us Something Useful
Oxford Finance Provides 50 Million Credit Facility To Kezar Life Sciences Inc Business Wire
Kezar Life Sciences Prepares For U S Ipo Nasdaq Kzr Seeking Alpha
Wells Fargo Analyst Has Questions On Kezar S Lupus Nephritis Data Readout Stock Plunges
Kezar Life Sciences Inc Kzr Stock Price News Info The Motley Fool
Kezar Life Sciences Key Catalysts Ahead Nasdaq Kzr Seeking Alpha
Kezar Life Sciences Announces Interim Results From The Mission Phase 2 Trial In Patients With Lupus Nephritis Kezar Life Sciences Inc Kzr
For Kezar Life Sciences John Fowler Variety Truly Is The Spice Of Life Biospace
Kezar Life Sciences Linkedin
Why Kezar Life Sciences Stock Is Soaring Today Nasdaq
Kezar Life Sciences Kzr Investor Presentation Slideshow Nasdaq Kzr Seeking Alpha
Kezar Life Sciences Targeting The Immunoproteasome To Treat Autoimmunity Nasdaq Kzr Seeking Alpha
Kezar Life Sciences Home Facebook
Kezar Life Sciences Crunchbase Company Profile Funding
Kezar Life Sciences Key Catalysts Ahead Nasdaq Kzr Seeking Alpha